Greenland Mines
GRML on Nasdaq. Biological products, (no diagnostic substances). Market value $573m.
Price checks use the past 12 months to September 2026. Some use the latest annual report instead, as marked. Quality checks use five annual reports, the latest for the year to December 2025.
We can't read total debt from the filing, so debt is left out.
Cash flow or capital spending isn't reported, so free cash flow is unknown.
Should I look at this?
Look carefully before going further
Why it could be worth it
Read the warning sign in its own filings
This is not advice. Check the numbers below.
We could not compute this from the filings.
The filings do not give us enough to work this out.
The filings do not give us enough to work this out.
Quality score: not known. Price score: 16 of 100. Our list needs 70 on quality and 60 on price.
$2.99 a share, 9% above its 1-year low
Over the past year the price has ranged from $2.75 to $37.00.
Pays no dividend
Prices from Friday’s close (20 November).
Five years of cash, in billions
| Revenue | ||||
| Revenue | n/a | n/a | n/a | n/a |
| Operating margin | ||||
| Operating margin | n/a | n/a | n/a | n/a |
| Debt to equity | ||||
| Debt to equity | n/a | n/a | n/a | n/a |
| Shares outstanding | ||||
| Shares outstanding | 0.01bn | 0.02bn | 0.07bn | 0.01bn |
Health checks
- Free cash flow positiveNot enough data
- Accounting looks honest (Beneish)Not enough data
- Financial strength (Piotroski)Not enough data
- Profit backed by cash (accruals)No
- DebtUnknown
- Revenue growth, five yearsUnknown
- Buying back its own sharesNo, 68% more shares since 2022
The quarter to September 2026
How the business did, compared with the same quarter a year earlier.
- A loss of $14 million, compared with a loss of $3 million a year ago.
- 349% more shares than a year ago. Each share owns a bit less of the company.
| Quarter to | Amount |
|---|---|
| December 2024 | -$2m |
| March 2025 | -$2m |
| June 2025 | -$4m |
| September 2025 | -$3m |
| December 2025 | -$2m |
| March 2026 | -$14m |
| June 2026 | -$4m |
| September 2026 | -$14m |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- n/a
- Last annual report (10-K)
- 1 April 2026
- Next quarterly (estimated, 10-Q)
- 15 February 2027
Who owns it
None of the long-term investors we follow own it. 48 funds in all.
Largest holders overall
- Meteora Capital$1m
- Citadel Advisors$1mNew
- Vanguard Capital Management$789,970Added
- Geode Capital Management$267,073Added
- Davidson Kempner Capital Management LP$260,000New
- Vanguard Fiduciary Trust$166,847Added
- Renaissance Technologies$118,842New
- State Street$78,650Added
- UBS Group AG$68,708Cut
- Northern Trust$64,319Added
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
2 investors own more than 5%.
- AnorTech Inc.Passive investor9.8%Since 6 November 2026
- Strategic EP, LLCPassive investorat least 5.5%(filed with 1 related holder)Since 4 March 2026
- Austria Capital LLCPassive investorSold down below 5%Since 14 May 2025
- Davidson Kempner Capital Management LPPassive investorSold down below 5%Since 30 September 2026
| Holder | Stake | Since | |
|---|---|---|---|
AnorTech Inc. Passive investor | 9.8% | 6 November 2026 | |
Strategic EP, LLC Passive investor | at least 5.5% (filed with 1 related holder) | 4 March 2026 | |
Austria Capital LLC Passive investor | Sold down below 5% | 14 May 2025 | |
Davidson Kempner Capital Management LP Passive investor | Sold down below 5% | 30 September 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
In the last 12 months, 3 insiders bought $462,126 of shares on the open market. 1 sold $40,250.
- LeBlanc JeffChief Financial OfficerBought
- Date
- 25 August 2026
- Shares
- 14,000
- Price
- $9.72
- Value
- $136,080
- Sawyer Jason DavidDirectorBought
- Date
- 22 July 2026
- Shares
- 240,000
- Price
- $0.23
- Value
- $55,944
- McGarity JonDirectorBought
- Date
- 20 July 2026
- Shares
- 140,000
- Price
- $0.18
- Value
- $24,822
- LeBlanc JeffChief Financial OfficerBought
- Date
- 16 July 2026
- Shares
- 1,400,000
- Price
- $0.18
- Value
- $245,280
- El-Dada Riad HusseinDirectorSold
- Date
- 25 June 2026
- Shares
- 175,000
- Price
- $0.23
- Value
- $40,250
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 25 August 2026 | LeBlanc Jeff Chief Financial Officer | Bought | 14,000 | $9.72 | $136,080 |
| 22 July 2026 | Sawyer Jason David Director | Bought | 240,000 | $0.23 | $55,944 |
| 20 July 2026 | McGarity Jon Director | Bought | 140,000 | $0.18 | $24,822 |
| 16 July 2026 | LeBlanc Jeff Chief Financial Officer | Bought | 1,400,000 | $0.18 | $245,280 |
| 25 June 2026 | El-Dada Riad Hussein Director | Sold | 175,000 | $0.23 | $40,250 |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
1 serious warning sign in Greenland Mines’ filings.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 1 Apr 2026, plus the 10-Q filed 16 Nov 2026 and 21 later 8-Ks.
Weak checks on its own accounts
SeriousThe company said its checks on its own accounts did not work at the end of its latest quarter. Mistakes could slip into the numbers.
“These remediation efforts are ongoing, and the material weaknesses described above had not been fully remediated as of September 30, 2026.”
Show the full paragraph
These remediation efforts are ongoing, and the material weaknesses described above had not been fully remediated as of September 30, 2026. Notwithstanding the material weaknesses, management believes that our condensed consolidated financial statements for the three and nine months ended September 30, 2026 are fairly stated, in all material respects, in accordance with U.S. GAAP.
From the 10-Q filed 16 November 2026, Part I, Item 4. Controls and Procedures. Read it in the filing
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
What could go wrong
Cheap for a reason is the question the numbers cannot answer.
Whether the price already reflects the risks is what the deep dive is for.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
A serious warning sign just appeared in its filings. Read what it says before you buy.
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.